Lakewood-Amedex Biotherapeutics Inc.
AI Executive Summary
AI-powered analysis of 10-Q filing content
Lakewood-Amedex faces severe liquidity crisis with cash dropping 95% to $11,709 while current liabilities exceed $3M. The company shows significant operational deterioration with 71% increase in net losses and 89% spike in general administrative expenses, indicating potential going concern issues.
Red Flags Detected (7)
Critical cash position of only $11,709 vs $3.03M current liabilities
95% cash burn from $236,400 to $11,709 in one quarter
Total stockholders' deficit worsened 45% to negative $2.84M
4 more red flags detected
Key Takeaways
Company has approximately 13 days of cash remaining at current burn rate
Stockholders' deficit indicates potential insolvency risk
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.